TDO2 and cancer: Enzymes, such as indoleamine-2,3-dioxygenase 1 (IDO1), IDO2, or tryptophan-2,3-dioxygenase, catalyze this, thereby modulating immunity and fostering cancer progression via tryptophan depletion and aryl hydrocarbon receptor activation [45].